SOURCE: Horizon Pharma plc

Horizon Pharma plc

January 29, 2015 16:05 ET

Horizon Pharma plc to Participate in Two Conferences in February

DUBLIN, IRELAND--(Marketwired - Jan 29, 2015) -  Horizon Pharma plc (NASDAQ: HZNP), a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs, today announced that Timothy P. Walbert, chairman, president and chief executive officer, will present at the following conferences in February.

  • 17th Annual BIO CEO & Investor Conference
    • Presentation Date: Tuesday, February 10, 2015
    • Presentation Time: 1:30pm E.T.
  • 2015 Leerink Global Healthcare Conference
    • Presentation Date: Thursday, February 12, 2015
    • Presentation Time: 3:05pm E.T.

The presentations will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com. A replay of the webcast will be available for 10 business days.

About Horizon Pharma plc
Horizon Pharma plc is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs. The Company markets a portfolio of products in arthritis, inflammation and orphan diseases. Horizon's U.S. marketed products are ACTIMMUNE® (interferon gamma-1b), DUEXIS® (ibuprofen/famotidine), PENNSAID® (diclofenac sodium topical solution) 2% w/w, RAYOS® (prednisone) delayed-release tablets and VIMOVO® (naproxen/esomeprazole magnesium). Horizon's global headquarters are in Dublin, Ireland. For more information, please visit www.horizonpharma.com.

Contact Information

  • Investor Contact:
    Robert F. Carey
    Executive Vice President, Chief Business Officer
    Email Contact
    +1 224-383-3250

    Media Contact:
    Geoff Curtis
    Email Contact
    +1 312-233-1253